What is she best known for?
The fields of study she is best known for:
- Cancer
- Gene
- Immune system
Elizabeth M. Jaffee focuses on Immunology, Immunotherapy, Immune system, Pancreatic cancer and Cancer.
In most of her Immunology studies, her work intersects topics such as Survival rate.
Her Immunotherapy research is multidisciplinary, relying on both Cancer research, Cyclophosphamide, Chemotherapy and Dendritic cell.
Her studies in Immune system integrate themes in fields like Cytokine and Granulocyte macrophage colony-stimulating factor.
The concepts of her Pancreatic cancer study are interwoven with issues in Clinical trial, Tissue microarray, Pancreatic disease and Cancer immunology.
She has researched Cancer in several fields, including Radiation therapy and Oncology.
Her most cited work include:
- Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses (3039 citations)
- Vaccination with Irradiated Tumor Cells Engineered to Secrete Murine Granulocyte-Macrophage Colony-Stimulating Factor Stimulates Potent, Specific, and Long-Lasting Anti-Tumor Immunity (2541 citations)
- Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens (1117 citations)
What are the main themes of her work throughout her whole career to date?
Elizabeth M. Jaffee mostly deals with Cancer research, Immunology, Immune system, Cancer and Immunotherapy.
Her studies deal with areas such as Cell, Antibody, Metastasis and Pancreatic cancer as well as Cancer research.
Her Pancreatic cancer research incorporates themes from Disease, GVAX and Pancreatic disease, Pancreas.
Her Immune system study frequently involves adjacent topics like Granulocyte macrophage colony-stimulating factor.
Her research integrates issues of Cytokine and Pathology in her study of Cancer.
Her Immunotherapy study incorporates themes from Melanoma and Oncology.
She most often published in these fields:
- Cancer research (37.91%)
- Immunology (37.91%)
- Immune system (31.15%)
What were the highlights of her more recent work (between 2018-2021)?
- Cancer research (37.91%)
- Internal medicine (26.80%)
- Immune system (31.15%)
In recent papers she was focusing on the following fields of study:
Cancer research, Internal medicine, Immune system, Oncology and Tumor microenvironment are her primary areas of study.
Her study in Cancer research is interdisciplinary in nature, drawing from both Cancer, Metastasis, Cell, T cell and CD8.
Her Internal medicine and GVAX, Pancreatic cancer, Chemotherapy, Adenocarcinoma and Disease investigations all form part of her Internal medicine research activities.
Her Immune system research incorporates elements of Myeloid, Carcinoma and Mass cytometry.
Her research in Oncology intersects with topics in Clinical endpoint, Clinical trial, Maintenance therapy and Nivolumab, Immunotherapy.
Her Immunotherapy research includes themes of Colorectal cancer and Melanoma.
Between 2018 and 2021, her most popular works were:
- Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic (425 citations)
- Cross-Species Single-Cell Analysis of Pancreatic Ductal Adenocarcinoma Reveals Antigen-Presenting Cancer-Associated Fibroblasts (249 citations)
- PD-L1 expression and tumor mutational burden are independent biomarkers in most cancers. (104 citations)
In her most recent research, the most cited papers focused on:
- Cancer
- Gene
- Immune system
The scientist’s investigation covers issues in Cancer research, Internal medicine, Oncology, Immunotherapy and Pancreatic cancer.
The various areas that Elizabeth M. Jaffee examines in her Cancer research study include Cell, Metastasis, Immune system and Cancer immunotherapy.
Her biological study spans a wide range of topics, including Mutation and Exome sequencing.
Elizabeth M. Jaffee has included themes like Mesothelin, Cancer, Clinical trial, Survival rate and Combination therapy in her Oncology study.
The study incorporates disciplines such as Biomarker, Colorectal cancer, Disease and Pancreatic ductal adenocarcinoma in addition to Immunotherapy.
Her Pancreatic cancer research is multidisciplinary, incorporating perspectives in Stroma, GVAX, Pancreas and Effector.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
